New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study

Published: Nov 08, 2012

Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation. The finding offers a potential new drug target for treating CF lung disease, which is a major cause of illness and death for people with CF.

Back to news